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Abstract 
 Open Science is an umbrella term that encompasses making study materials, 
data, results and publications freely available. This not only enables wider 
dissemination of research findings (including to non-academics), but also promotes 
greater transparency and may improve the robustness and reproducibility of 
published research. 
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Opening Up Science 
 
There is growing consideration of the possibility that many published research 
findings may be false (1). While cases of fraud and data fabrication do exist, arguably 
a greater problem is the wider incentive structures in science that reward discovery 
and novelty over replication. This in turn may encourage various behaviours that 
reduce the likelihood that a research finding will prove robust, such as running a 
series of small, underpowered, but ultimately publishable studies, or conducting a 
large number of statistical analyses and only reporting those that produce the most 
interesting results. For example, the average statistical power of individual studies 
has been estimated to be as low as 20% in some domains (2), while the introduction 
of the requirement that clinical trial primary outcomes be pre-registered prior to 
publication was associated with a reduction in the number of trials that showed a 
significant benefit of intervention on the (reported) primary outcome (3). While there 
is ongoing debate as to the nature and extent of the reproducibility “crisis” (as it has 
become known), it is timely to reflect on whether the process of scientific research 
can be improved. 
A number of potential ways to improve reproducibility have been proposed 
(such as pre-registration of studies and analysis plans) (4, 5), many of which form 
part of what has become known as the Open Science movement. This encourages 
scientists to make their materials, data, and publications freely available to all. In its 
broadest sense, it includes open source software, open peer review (such as that 
practiced by the Frontiers family of journals) (6), and other resources (such as 
educational materials). A number of third-party services now exist to support Open 
Science, such as the Open Science Framework (OSF), a free, open-source service 
provided by the non-profit Center for Open Science (http://centerforopenscience.org). 
However, the principal motivation of the Open Science movement is not 
reproducibility but rather to promote wider access to the products of scientific 
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research (much of which is ultimately funded by public money or charitable 
donations), greater efficiency (through the sharing of materials and data), and 
improved quality control (through the ability to re-analyze data independently, but 
also as a result of the natural tendency to check one’s own data one more time if 
these are to be made public!). 
In addition to the advantages of adopting an Open Science model to science 
(e.g., increased efficiency through the sharing of materials and data) and the wider 
community (e.g., free access to research outputs), there are potential benefits to 
individual scientists and research groups. For example, it may encourage the 
harmonization of procedures within (and between) research groups, and improve 
quality control procedures (7). Nevertheless, adopting an Open Science approach 
can be a substantial undertaking, and may entail changes in procedures, the use of a 
number of platforms to make materials, data, and publications publicly available, and 
discussions with institutional ethics committees and research governance teams. 
Critically, certain aspects of Open Science may not be appropriate in some settings. 
For example, if there is a risk of participant identification in an anonymised data set 
(e.g., where the sample is drawn from a small, distinctive clinical population), 
particularly where sensitive information is involved, making data publicly available will 
not be appropriate. Pre-registration of study protocols may not be appropriate for 
exploratory research, or for secondary analyses of existing data. Any general move 
in the scientific community towards an Open Science model will necessarily be 
gradual, and will need to with genuine concerns that may exist about certain aspects 
of the model in specific settings. 
Recently the OSF introduced Transparency and Openness Promotion (TOP) 
Guidelines for journals and publishers (http://cos/io/top). These introduce eight 
standards that encourage greater openness - in brief, they cover citation standards, 
data, analytic methods (code), research materials, design and analysis, pre-
registration of studies, pre-registration of analysis plans, and replication (8). Not all of 
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these standards are applicable to all journals or disciplines, and therefore three 
levels for each standard are defined, with Level 1 presenting the fewest barriers to 
adoption (e.g., simply stating in the text of an article whether data are available, and 
if so where) and Level 3 representing the most stringent standards (e.g., mandating 
the deposition of data to a trusted repository and reported analyses reproduced 
independently prior to publication). Critically, these levels also allow for various 
aspects of the Open Science model to be adopted gradually, and allow journals to 
only adopt the guidelines up to a level that is appropriate in that field. 
 The principles of Open Science movement are not new – calls to improve the 
accessibility of data go back many years (9), while pre-registration is now the norm 
for clinical trials. However, if Open Science is to become the norm this will require a 
cultural change that will come about through both top-down and bottom-up activity. 
The former includes funders and publishers – for example, research funders are 
increasingly mandating data sharing and open access publication, while a number of 
journals (including Addiction) are signatories to the TOP Guidelines (8). At the same 
time, individual researchers and research groups can work to promote this cultural 
change, through training of early career researchers and the promotion of the 
principles of Open Science (7). It will also require a wider discussion within the 
scientific community of the potential advantages of the Open Science model, as well 
as barriers to adoption, including cases where exceptions will need to be made, and 
what new approaches and platforms are required to support it. 
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